Prime, Shock, and Kill: Priming CD4 T Cells from HIV Patients with a BCL-2 Antagonist before HIV Reactivation Reduces HIV Reservoir Size.
about
Casp8p41: The Protean Mediator of Death in CD4 T-cells that Replicate HIVPotent and Broad Inhibition of HIV-1 by a Peptide from the gp41 Heptad Repeat-2 Domain Conjugated to the CXCR4 Amino TerminusIncreasing procaspase 8 expression using repurposed drugs to induce HIV infected cell death in ex vivo patient cells.Factors Associated with the Size of HIV DNA Reservoir.Cell-Mediated Immunity to Target the Persistent Human Immunodeficiency Virus Reservoir.Challenges and strategies for the eradication of the HIV reservoir.Cancer therapies in HIV cure research.Tyrosine kinase inhibitors: potential use and safety considerations in HIV-1 infection.Maintenance of the HIV Reservoir Is Antagonized by Selective BCL2 Inhibition.HIV-infected macrophages and microglia that survive acute infection become viral reservoirs by a mechanism involving Bim.Antiviral Properties of Chemical Inhibitors of Cellular Anti-Apoptotic Bcl-2 Proteins.The latest science from the IAS Towards an HIV Cure Symposium: 16-17 July 2016, Durban, South Africa.An advanced BLT-humanized mouse model for extended HIV-1 cure studies.Curaxin CBL0100 Blocks HIV-1 Replication and Reactivation through Inhibition of Viral Transcriptional Elongation.Both HIV-Infected and Uninfected Cells Express TRAILshort, Which Confers TRAIL Resistance upon Bystander Cells within the Microenvironment.Getting the "Kill" into "Shock and Kill": Strategies to Eliminate Latent HIV.HIV Protease-Generated Casp8p41, When Bound and Inactivated by Bcl2, Is Degraded by the Proteasome.
P2860
Q28069817-7FA76B34-0801-4B7B-8749-69DFD6E1C6F2Q36195192-044DE3F7-2F50-4877-A5E4-F8210D971A4EQ36409179-CE08DC81-6A6F-403F-8C58-D2A2ECF2534CQ37615584-D039E28B-43DC-4FF2-846F-AD513F5AE012Q38777005-78641B04-8370-4771-994B-073FE19DFC77Q38862056-20C4E0B0-3789-47F3-A62C-6BD8F44AF7FBQ38949445-A71846C8-03A2-46C0-8889-5026DD30FA76Q39226064-4488F0D8-9D01-4293-AC86-C583E73702C9Q40279377-30F2B57D-E3A3-486D-ACB8-8237C20D3B41Q41921236-42EA911B-0295-432D-B3B9-2DA28F7683E4Q41930599-A2E55239-55BF-4DF3-80F1-FF140DD6D401Q42380882-3E0352A0-5400-4C6C-A6CD-4E846B32B469Q46813659-9DC82068-E9DE-45ED-AB99-C909E9EBBDDFQ47201695-983A8D7C-CAC7-4D4B-A80B-0D70CF1F9A4BQ47269298-08F33620-6A55-4036-B997-9F6769E31724Q47555333-A714021A-91F4-4926-98A1-A04A6BFF7BE9Q52324513-C16FED97-A357-4321-990D-758A6E584D74
P2860
Prime, Shock, and Kill: Priming CD4 T Cells from HIV Patients with a BCL-2 Antagonist before HIV Reactivation Reduces HIV Reservoir Size.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Prime, Shock, and Kill: Primin ...... on Reduces HIV Reservoir Size.
@en
Prime, Shock, and Kill: Primin ...... on Reduces HIV Reservoir Size.
@nl
type
label
Prime, Shock, and Kill: Primin ...... on Reduces HIV Reservoir Size.
@en
Prime, Shock, and Kill: Primin ...... on Reduces HIV Reservoir Size.
@nl
prefLabel
Prime, Shock, and Kill: Primin ...... on Reduces HIV Reservoir Size.
@en
Prime, Shock, and Kill: Primin ...... on Reduces HIV Reservoir Size.
@nl
P2093
P2860
P50
P356
P1433
P1476
Prime, Shock, and Kill: Primin ...... on Reduces HIV Reservoir Size.
@en
P2093
Amy M Sainski
Andrew D Badley
Daniel O'Brien
Gary D Bren
Joseph D Yao
Maria Cristina Miranda de Araujo Correia
Nathan W Cummins
Rahul Sampath
Sekar Natesampillai
Stacey A Rizza
P2860
P304
P356
10.1128/JVI.03179-15
P407
P577
2016-02-03T00:00:00Z